Inhibition by adenosine A(2A) receptors of NMDA but not AMPA currents in rat neostriatal neurons.

PubWeight™: 0.99‹?› | Rank: Top 15%

🔗 View Article (PMC 1572053)

Published in Br J Pharmacol on May 01, 2000

Authors

K Wirkner1, H Assmann, L Köles, Z Gerevich, H Franke, W Nörenberg, R Boehm, P Illes

Author Affiliations

1: Department of Pharmacology, University of Leipzig, Härtelstrasse 16-18, D-04107 Leipzig, Germany.

Articles citing this

Adenosine A2A receptors and basal ganglia physiology. Prog Neurobiol (2007) 1.90

Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: implications for striatal neuronal function. Proc Natl Acad Sci U S A (2002) 1.30

Adenosine hypothesis of schizophrenia--opportunities for pharmacotherapy. Neuropharmacology (2011) 1.02

Selective inactivation of adenosine A(2A) receptors in striatal neurons enhances working memory and reversal learning. Learn Mem (2011) 1.01

Neuroprotection by caffeine and adenosine A2A receptor blockade of beta-amyloid neurotoxicity. Br J Pharmacol (2003) 1.01

Functional selectivity of adenosine receptor ligands. Purinergic Signal (2011) 0.93

Tuning and fine-tuning of synapses with adenosine. Curr Neuropharmacol (2009) 0.89

Interaction of P2 purinergic receptors with cellular macromolecules. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.86

G protein-independent neuromodulatory action of adenosine on metabotropic glutamate signalling in mouse cerebellar Purkinje cells. J Physiol (2007) 0.86

Adenosine A2A receptor in the monkey basal ganglia: ultrastructural localization and colocalization with the metabotropic glutamate receptor 5 in the striatum. J Comp Neurol (2012) 0.84

VIP enhances both pre- and postsynaptic GABAergic transmission to hippocampal interneurones leading to increased excitatory synaptic transmission to CA1 pyramidal cells. Br J Pharmacol (2004) 0.82

Release inhibitory receptors activation favours the A2A-adenosine receptor-mediated facilitation of noradrenaline release in isolated rat tail artery. Br J Pharmacol (2002) 0.80

Modulation of excitatory neurotransmission by neuronal/glial signalling molecules: interplay between purinergic and glutamatergic systems. Purinergic Signal (2015) 0.78

Interaction between intrathecal gabapentin and adenosine in the formalin test of rats. J Korean Med Sci (2004) 0.75

Invited Lectures : Overviews Purinergic signalling: past, present and future. Purinergic Signal (2006) 0.75

Transient adenosine release is modulated by NMDA and GABAB receptors. ACS Chem Neurosci (2017) 0.75

Articles cited by this

Inositol phosphates and cell signalling. Nature (1989) 17.78

Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem (1982) 16.71

A thin slice preparation for patch clamp recordings from neurones of the mammalian central nervous system. Pflugers Arch (1989) 6.98

Nomenclature and classification of purinoceptors. Pharmacol Rev (1994) 5.32

Characterization of inositol trisphosphate receptor binding in brain. Regulation by pH and calcium. J Biol Chem (1987) 4.46

JPCalc, a software package for calculating liquid junction potential corrections in patch-clamp, intracellular, epithelial and bilayer measurements and for correcting junction potential measurements. J Neurosci Methods (1994) 4.33

[3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain. J Pharmacol Exp Ther (1989) 4.18

A potent synthetic peptide inhibitor of the cAMP-dependent protein kinase. J Biol Chem (1986) 3.49

The newly synthesized selective Ca2+/calmodulin dependent protein kinase II inhibitor KN-93 reduces dopamine contents in PC12h cells. Biochem Biophys Res Commun (1991) 3.04

Receptor-coupled signal transduction in human polymorphonuclear neutrophils: effects of a novel inhibitor of phospholipase C-dependent processes on cell responsiveness. J Pharmacol Exp Ther (1990) 2.89

Synaptic- and agonist-induced excitatory currents of Purkinje cells in rat cerebellar slices. J Physiol (1991) 2.84

Calcium-induced actin depolymerization reduces NMDA channel activity. Neuron (1993) 2.59

The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones. Trends Neurosci (1990) 2.54

Competitive binding of alpha-actinin and calmodulin to the NMDA receptor. Nature (1997) 2.41

Characterization of protein kinase A and protein kinase C phosphorylation of the N-methyl-D-aspartate receptor NR1 subunit using phosphorylation site-specific antibodies. J Biol Chem (1997) 2.25

A novel highly specific and potent inhibitor of calmodulin-dependent protein kinase II. Biochem Biophys Res Commun (1995) 2.19

Adenosine receptor subtypes: characterization and therapeutic regulation. Annu Rev Pharmacol Toxicol (1995) 2.19

Regulation of NMDA channel function by endogenous Ca(2+)-dependent phosphatase. Nature (1994) 2.07

Identification of a phosphorylation site for calcium/calmodulindependent protein kinase II in the NR2B subunit of the N-methyl-D-aspartate receptor. J Biol Chem (1996) 1.91

Inactivation of NMDA channels in cultured hippocampal neurons by intracellular calcium. J Neurosci (1993) 1.83

Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease. Trends Pharmacol Sci (1997) 1.79

Striatal restricted adenosine A2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study. J Neurochem (1991) 1.69

Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions. Trends Neurosci (1994) 1.63

Anatomical aspects of information processing in primate basal ganglia. Trends Neurosci (1993) 1.62

Enhancement of the glutamate response by cAMP-dependent protein kinase in hippocampal neurons. Science (1991) 1.56

Participation of postsynaptic PKC in cerebellar long-term depression in culture. Science (1991) 1.55

Membrane properties and synaptic responses of rat striatal neurones in vitro. J Physiol (1991) 1.48

8-(3-Chlorostyryl)caffeine (CSC) is a selective A2-adenosine antagonist in vitro and in vivo. FEBS Lett (1993) 1.47

2-Chloro-N6-cyclopentyladenosine: a highly selective agonist at A1 adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol (1988) 1.47

Dopaminergic modulation of NMDA-induced whole cell currents in neostriatal neurons in slices: contribution of calcium conductances. J Neurophysiol (1998) 1.46

Anion permeation in GABA- and glycine-gated channels of mammalian cultured hippocampal neurons. Proc Biol Sci (1993) 1.43

Beta-adrenergic regulation of synaptic NMDA receptors by cAMP-dependent protein kinase. Neuron (1996) 1.39

Protein kinase C modulation of NMDA currents: an important link for LTP induction. Trends Neurosci (1992) 1.39

Effects of the selective adenosine A2 receptor agonist CGS 21680 on in vitro electrophysiology, cAMP formation and dopamine release in rat hippocampus and striatum. J Pharmacol Exp Ther (1990) 1.37

Competitive cAMP antagonists for cAMP-receptor proteins. J Biol Chem (1984) 1.33

Phosphorylation of ligand-gated ion channels: a possible mode of synaptic plasticity. FASEB J (1992) 1.32

Adenosine A2 receptor-mediated excitatory actions on the nervous system. Prog Neurobiol (1996) 1.24

Pharmacology of adenosine A2A receptors. Trends Pharmacol Sci (1996) 1.23

The striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain. J Neurosci (1993) 1.18

Protein kinase C: is its pivotal role in cellular activation over-stated? Trends Pharmacol Sci (1994) 1.13

Intracellular studies on the dopamine-induced firing inhibition of neostriatal neurons in vitro: evidence for D1 receptor involvement. Neuroscience (1987) 1.12

Modulation of amino acid-gated ion channels by protein phosphorylation. Int Rev Neurobiol (1996) 1.12

Ethanol tolerance and synaptic plasticity. Trends Pharmacol Sci (1998) 1.09

Specific inhibition of calcineurin by type II synthetic pyrethroid insecticides. Biochem Pharmacol (1992) 1.07

Excitatory amino acids in synaptic excitation of rat striatal neurones in vitro. J Physiol (1988) 1.06

Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens. Brain Res Brain Res Rev (1994) 1.03

The role of adenosine A2a receptors in regulating GABAergic synaptic transmission in striatal medium spiny neurons. J Neurosci (1996) 1.02

Adenosine A2a receptor modulation of electrically evoked endogenous GABA release from slices of rat globus pallidus. J Neurochem (1993) 0.99

Morphological and physiological properties of neostriatal neurons: an intracellular horseradish peroxidase study in the rat. Neuroscience (1982) 0.97

Inhibition by nitrobenzylthioinosine of adenosine uptake by asynchronous HeLa cells. Mol Pharmacol (1977) 0.97

A2 adenosine receptors: their presence and neuromodulatory role in the central nervous system. Gen Pharmacol (1996) 0.94

Recurrent inhibition in the rat neostriatum. Brain Res (1980) 0.94

Effect of adenosine and some of its structural analogues on the conductance of NMDA receptor channels in a subset of rat neostriatal neurones. Br J Pharmacol (1997) 0.90

The cytoskeleton and neurotransmitter receptors. Int Rev Neurobiol (1996) 0.87

Adenosine A2A receptors inhibit the conductance of NMDA receptor channels in rat neostriatal neurons. Amino Acids (1998) 0.86

The G protein-channel connection. Trends Neurosci (1990) 0.84

N6-bicycloalkyladenosines with unusually high potency and selectivity for the adenosine A1 receptor. J Med Chem (1989) 0.83

Calmodulin antagonists' binding sites on calmodulin. Pharmacology (1983) 0.83

Articles by these authors

P2X receptors and nociception. Pharmacol Rev (2001) 1.80

[Traditional camel medicine in China]. Sudhoffs Arch (1997) 1.40

Identification of the neuroeffector transmitter in jejunal branches of the rabbit mesenteric artery. Naunyn Schmiedebergs Arch Pharmacol (1987) 1.32

Neuronal ATP receptors and their mechanism of action. Trends Pharmacol Sci (1993) 1.31

Neuronal P2X receptors: localisation and functional properties. Naunyn Schmiedebergs Arch Pharmacol (2000) 1.30

Endocytosis and vesicle trafficking during tip growth of root hairs. Protoplasma (2005) 1.24

Valve repair in mitral regurgitation complicated by severe annulus calcification. Ann Thorac Surg (2000) 1.21

Role of ATP in fast excitatory synaptic potentials in locus coeruleus neurones of the rat. Br J Pharmacol (1997) 1.21

Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum. Neuroscience (1998) 1.21

P2X7 receptors in Müller glial cells from the human retina. J Neurosci (2000) 1.16

Assessment of nonarticular tenderness and prevalence of fibromyalgia in children. J Rheumatol (1993) 1.15

[Studies on the ultrastructure and permeability of the term amnion with special reference to the microfilamentous and microtubular structures (author's transl)]. Arch Gynakol (1978) 1.12

Reply to: 'the discovery of a new class of synaptic transmitters in smooth muscle fifty years ago and amelioration of coronary artery thrombosis'. Acta Physiol (Oxf) (2013) 1.09

Hydrocortisone reinforces the blood-brain barrier properties in a serum free cell culture system. Biochem Biophys Res Commun (1998) 1.08

Identification of a plastoquinone and two naphthoquinones in Anacystis nidulans by NMR and mass spectroscopy. Biochem Biophys Res Commun (1967) 1.08

Specific activities of individual c-Jun N-terminal kinases in the brain. Neuroscience (2009) 1.07

Hydrocortisone reinforces the blood-brain properties in a serum free cell culture system. Biochem Biophys Res Commun (1998) 1.07

Calcium reverses the inhibitory action of morphine on neuroeffector transmission in the mouse vas deferens. Brain Res (1980) 1.07

Biochemical and morphological studies on production and regression of experimental liver cirrhosis induced by thioacetamide in Uje: WIST rats. Z Versuchstierkd (1987) 1.03

A comparative analysis of the activity of ligands acting at P2X and P2Y receptor subtypes in models of neuropathic, acute and inflammatory pain. Br J Pharmacol (2010) 1.02

P2 receptors meet the immune system. Trends Pharmacol Sci (2001) 1.01

Voltage-dependent potassium channels in activated rat microglia. J Physiol (1994) 1.01

P2X receptor expression on astrocytes in the nucleus accumbens of rats. Neuroscience (2001) 1.01

Inhibition of noradrenaline release by omega-conotoxin GVIA in the rat tail artery. Br J Pharmacol (1989) 0.99

P2 receptor-types involved in astrogliosis in vivo. Br J Pharmacol (2001) 0.99

An electrophysiological study of presynaptic alpha-adrenoceptors in the vas deferens of the mouse. Br J Pharmacol (1983) 0.99

Presynaptic inhibitory opioid delta- and kappa-receptors in a branch of the rabbit ileocolic artery. Eur J Pharmacol (1985) 0.99

Effects of the central analgesic tramadol and its main metabolite, O-desmethyltramadol, on rat locus coeruleus neurones. Br J Pharmacol (1993) 0.99

The blocking effects of omega-conotoxin on Ca current in bovine chromaffin cells. Neurosci Lett (1990) 0.98

4-Aminopyridine and evoked transmitter release from motor nerve endings. Br J Pharmacol (1978) 0.97

Galanin receptors inhibit the spontaneous firing of locus coeruleus neurones and interact with mu-opioid receptors. Eur J Pharmacol (1993) 0.96

Inflammatory stimuli induce a new K+ outward current in cultured rat microglia. Neurosci Lett (1992) 0.95

Co-transmitter function of ATP in central catecholaminergic neurons of the rat. Neuroscience (2001) 0.95

P2 receptor-mediated proliferative effects on astrocytes in vivo. Glia (1999) 0.95

Mechanism of inhibition by ethanol of NMDA and AMPA receptor channel functions in cultured rat cortical neurons. Naunyn Schmiedebergs Arch Pharmacol (2000) 0.95

Characterization and transduction mechanisms of purinoceptors in activated rat microglia. Br J Pharmacol (1994) 0.94

Quantification of the cell kinetic effects of G-CSF using a model of human granulopoiesis. Exp Hematol (1993) 0.94

Characterization and possible function of adenosine 5'-triphosphate receptors in activated rat microglia. Br J Pharmacol (1994) 0.94

P2 receptor-mediated stimulation of the PI3-K/Akt-pathway in vivo. Glia (2009) 0.94

Excitatory effects of adenosine 5'-triphosphate on rat locus coeruleus neurones. Eur J Pharmacol (1992) 0.93

Metabotropic P2Y receptors inhibit P2X3 receptor-channels via G protein-dependent facilitation of their desensitization. Br J Pharmacol (2007) 0.93

P2Y receptor expression on astrocytes in the nucleus accumbens of rats. Neuroscience (2004) 0.93

Increase of intracellular Ca2+ by P2X and P2Y receptor-subtypes in cultured cortical astroglia of the rat. Neuroscience (2009) 0.93

Depolarization of rat locus coeruleus neurons by adenosine 5'-triphosphate. Neuroscience (1992) 0.92

Increased polysialic acid neural cell adhesion molecule expression in human hippocampus of heroin addicts. Neuroscience (2006) 0.91

The c-Jun N-terminal kinase (JNK) inhibitor XG-102 enhances the neuroprotection of hyperbaric oxygen after cerebral ischaemia in adult rats. Neuropathol Appl Neurobiol (2009) 0.91

Mechanisms of receptor-mediated modulation of transmitter release in noradrenergic, cholinergic and sensory neurones. Neuroscience (1986) 0.91

ATP stimulation of Ca2+ -dependent plasminogen release from cultured microglia. Br J Pharmacol (1998) 0.90

Effect of adenosine and some of its structural analogues on the conductance of NMDA receptor channels in a subset of rat neostriatal neurones. Br J Pharmacol (1997) 0.90

Characterization of opioid receptors modulating noradrenaline release in the hippocampus of the rabbit. J Neurochem (1986) 0.89

Oxygen delivery in perfused rat kidney: NADH fluorescence and renal functional state. Am J Physiol (1976) 0.89

Molecular mechanisms of microglial activation. B. Voltage- and purinoceptor-operated channels in microglia. Neurochem Int (1996) 0.89

Endogenous thrombopoietin serum levels during multicycle chemotherapy. Br J Haematol (1999) 0.89

Inhibitory adenosine A1-receptors on rat locus coeruleus neurones. An intracellular electrophysiological study. Naunyn Schmiedebergs Arch Pharmacol (1990) 0.89

Modulation of transmitter and hormone release by multiple neuronal opioid receptors. Rev Physiol Biochem Pharmacol (1989) 0.88

Coexistence of purino- and pyrimidinoceptors on activated rat microglial cells. Br J Pharmacol (1997) 0.88

How many myeloid post-progenitor cells have to be transplanted to completely abrogate neutropenia after peripheral blood progenitor cell transplantation? Results of a computer simulation. Exp Hematol (1999) 0.87

Regulation of somatodendritic GABAA receptor channels in rat hippocampal neurons: evidence for a role of the small GTPase Rac1. J Neurosci (2000) 0.87

Improved net sodium transport of the isolated rat kidney. Z Gesamte Exp Med (1971) 0.87

Inhibition of neuroeffector transmission by morphine in the vas deferens of naive and morphine-treated mice. Br J Pharmacol (1980) 0.87

Neuroprotective effects of the P2 receptor antagonist PPADS on focal cerebral ischaemia-induced injury in rats. Eur J Neurosci (2006) 0.87

Neuroprotection by ATP-dependent potassium channels in rat neocortical brain slices during hypoxia. Neurosci Lett (1999) 0.87

Laparoscopic repair of an extrahiatal hernia caused by congenital dysplasia: a case report. Surg Endosc (2001) 0.87

Low temperature prevents potentiation of norepinephrine release by phenylephrine. Neurochem Int (2001) 0.87

Alpha2-adrenoceptor-mediated inhibition of cultured sympathetic neurons: changes in alpha2A/D-adrenoceptor-deficient mice. Naunyn Schmiedebergs Arch Pharmacol (2001) 0.86

Expression of an outwardly rectifying K+ channel in rat microglia cultivated on teflon. Neurosci Lett (1993) 0.86

Blockade of alpha 2-adrenoceptors permits the operation of otherwise silent opioid kappa-receptors at the sympathetic axons of rabbit jejunal arteries. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.86

Purinergic modulation of glutamate release under ischemic-like conditions in the hippocampus. Neuroscience (2007) 0.86

Nucleotides as cotransmitters in vascular sympathetic neuroeffector transmission. Blood Vessels (1991) 0.86

Involvement of P2X and P2Y receptors in microglial activation in vivo. Purinergic Signal (2007) 0.86

Adenosine A2A receptors inhibit the conductance of NMDA receptor channels in rat neostriatal neurons. Amino Acids (1998) 0.86

NMDA receptor characterization and subunit expression in rat cultured mesencephalic neurones. Br J Pharmacol (1999) 0.86

Critical validation of colour Doppler ultrasound in diagnostics of acute scrotum in children. Eur J Pediatr Surg (2003) 0.86

Blockade of alpha 2-adrenoceptors increases opioid mu-receptor-mediated inhibition of the firing rate of rat locus coeruleus neurones. Naunyn Schmiedebergs Arch Pharmacol (1990) 0.86

Acamprosate inhibits Ca2+ influx mediated by NMDA receptors and voltage-sensitive Ca2+ channels in cultured rat mesencephalic neurones. Naunyn Schmiedebergs Arch Pharmacol (2000) 0.86

UTP- and ATP-triggered transmitter release from rat sympathetic neurones via separate receptors. Br J Pharmacol (1995) 0.86

Functional coupling of neonatal rat Sertoli cells and gonocytes in coculture. Endocrinology (1990) 0.86

Neuroreceptors and ion channels as targets of alcohol. Alcohol Clin Exp Res (2001) 0.85

[Convalescence and rehabilitation following stomach operations]. Internist (Berl) (1965) 0.85

Purine ionotropic (P2X) receptors. Curr Pharm Des (2007) 0.85

Beta-endorphin-sensitive opioid receptors in the rat tail artery. Naunyn Schmiedebergs Arch Pharmacol (1987) 0.85

Lack of detectable DNA alkylation for bromhexine in man. Arzneimittelforschung (1988) 0.85

Ethanol-induced inhibition of NMDA receptor channels. Neurochem Int (1999) 0.84

Role of action potentials and calcium influx in ATP- and UDP-induced noradrenaline release from rat cultured sympathetic neurones. Naunyn Schmiedebergs Arch Pharmacol (1999) 0.84

Acute hexachlorophene encephalopathy: clinico-neuropathological correlation. Acta Neuropathol (1974) 0.84

Conformational flexibility of the agonist binding jaw of the human P2X3 receptor is a prerequisite for channel opening. Br J Pharmacol (2014) 0.84

P2 receptor expression in the dopaminergic system of the rat brain during development. Neuroscience (2007) 0.84

The unusual state-dependent affinity of P2X3 receptors can be explained by an allosteric two-open-state model. Mol Pharmacol (2007) 0.84

Role of cyclic AMP in the prejunctional alpha 2-adrenoceptor modulation of noradrenaline release from the rat tail artery. Naunyn Schmiedebergs Arch Pharmacol (1990) 0.84